37(top 2%)
papers
1.0K(top 2%)
citations
20(top 1%)
h-index
32(top 2%)
g-index
37
all documents
1.0K
doc citations
388
citing journals

Top Articles

#TitleJournalYearCitations
1A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic responseCancer Chemotherapy and Pharmacology1989144
2Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised studyBritish Journal of Cancer1993100
3Intermittent high-dose tamoxifen as a potential modifier of multidrug resistanceEuropean Journal of Cancer199266
4The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin.BMJ: British Medical Journal198857
5Glutathione and related enzyme activity in human lung cancer cell linesBritish Journal of Cancer198856
6Zoladex: Endocrine and therapeutic effects in post-menopausal breast cancerBritish Journal of Cancer198949
7Arginine vasopressin – a mediator of chemotherapy induced emesis?British Journal of Cancer198943
8Allergic reactions to carboplatinAnnals of Oncology199243
9Phase II study of the antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717) in advanced breast cancerEuropean Journal of Cancer & Clinical Oncology198841
10Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancerBritish Journal of Cancer200139
11The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16–213, doxorubicin and vincristine (VPAV) for small cell lung cancerEuropean Journal of Cancer & Clinical Oncology198835
12A phase II trial of ifosfamide/mesna with doxorubicin for malignant mesotheliomaEuropean Journal of Cancer & Clinical Oncology198930
13A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancerBritish Journal of Cancer199227
14High-Dose (480 mg/day) Tamoxifen with Etoposide: A Study of a Potential Multi-Drug Resistance ModulatorOncology199426
15BACK PAIN—A PRESENTATION OF METASTATIC TESTICULAR GERM CELL TUMOURSLancet, The198723
16Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancerCancer199023
17Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancerCancer Chemotherapy and Pharmacology199523
18A phase II study of the platinum analogues JM8 and JM9 in malignant pleural mesotheliomaCancer Chemotherapy and Pharmacology198621
19A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcomaCancer Chemotherapy and Pharmacology198821
20Verapamil with mitoxantrone for advanced ovarian cancer: A negative phase II trialAnnals of Oncology199121
21Intravenous infusions of ifosfamide/mesna and perturbation of warfarin anticoagulant control.Postgraduate Medical Journal199017
22Single high-dose (45 mg) infusions of aminohydroxypropylidene diphosphonate for severe malignant hypercalcemiaCancer198915
23Gynaecomastia and extragonadal symptoms leading to diagnosis delay of germ cell tumours in young men.Postgraduate Medical Journal199115
24Phase II study of low dose aminoglutethimide 250 mg/day plus hydrocortisone in advanced postmenopausal breast cancerEuropean Journal of Cancer & Clinical Oncology198914
25Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481)European Journal of Cancer199514
26Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancerBritish Journal of Cancer199113
27Thromboses and thromboemboli in patients with lymphoma during cytotoxic chemotherapy.BMJ: British Medical Journal198812
28Zoladex: Therapeutic Effects in Postmenopausal Breast CancerHormone Research19899
29Cisplatin with high-dose infusions of hydroxyurea to inhibit DNA repairCancer Chemotherapy and Pharmacology19899
30Metastatic Breast Cancer Presenting with Diabetes InsipidusActa Oncológica19927
31The efficacy of 5-fluorouracil in human colorectal cancer is not enhanced by thymidylate synthetase inhibition with CB3717 (N10-propargyl-5,8 dideazafolic acid)British Journal of Cancer19886
32Results of chemotherapy using ifosfamide with doxorubicin in advanced breast cancerBreast Cancer Research and Treatment19944
33Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancerCancer Chemotherapy and Pharmacology19863
34Fixed dose short course mitomyucin C with vincristine in advanced pre-treated breast cancerAnnals of Oncology19903
35Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancerCancer Chemotherapy and Pharmacology19951
36Reversal of Duodenal Obstruction due to Metastatic Teratoma by Combination ChemotherapyBritish Journal of Urology19890
37Assessment of renal toxicity by urinary enzymes in patients receiving chemotherapy with 8-methyl-8-acetylenic-putrescineCancer Chemotherapy and Pharmacology19900